Very interestingly, also in B-ALL primary cells, as observed in B-ALL cell lines, the drug combination induced Ser536 p-NF-κB and a concomitant p-IκBα increase (Figure 6B). The gene discussed is NFKBIA; the disease is acute lymphoblastic leukemia.